Hester Biosciences Limited (NSE:HESTERBIO)
India · Delayed Price · Currency is INR 2,340.60
+31.70 (1.37%)
Nov 11, 2026, 2:10 PM IST
Hester Biosciences Market Cap
Hester Biosciences has a market cap or net worth of 19.76 billion as of November 10, 2026. Its market cap has increased by 43.21% in one year.
Market Cap
19.76B
Enterprise Value
20.65B
Revenue
3.45B
Global Rank
n/a
Country Rank
n/a
PE Ratio
14.18
ChartMarket Cap Chart
Since October 11, 1996, Hester Biosciences's market cap has increased from 22.04M to 19.76B, an increase of 89,524.27%. That is a compound annual growth rate of 25.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 19.76B | 45.89% |
| Dec 31, 2025 | 13.54B | -33.49% |
| Dec 31, 2024 | 20.36B | 64.06% |
| Dec 29, 2023 | 12.41B | -18.54% |
| Dec 30, 2022 | 15.24B | -29.34% |
| Dec 31, 2021 | 21.56B | 48.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 42.95B |
| Solara Active Pharma Sciences | 31.31B |
| Ind-Swift Laboratories | 30.52B |
| Sakar Healthcare | 22.85B |
| Indoco Remedies | 20.31B |
| Windlas Biotech | 20.06B |
| Beta Drugs | 19.07B |
| Anlon Healthcare | 14.31B |